Sponsor Pipeline

Neowise Biotechnology Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07266298 TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors Solid Metastatic Tumor Recruiting
Get alerts when Neowise Biotechnology's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free